Institute of Medical Science, University of Toronto, Toronto, Canada.
Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Cochrane Database Syst Rev. 2023 Aug 10;8(8):CD004030. doi: 10.1002/14651858.CD004030.pub4.
Maintaining adequate nutrition is critical for people with amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND). Enteral tube feeding is offered to people experiencing difficulty swallowing (dysphagia) to prevent weight loss and aspiration pneumonia. Among the types of enteral tube feeding, percutaneous endoscopic gastrostomy (PEG) is the typical procedure offered to people with ALS and will be mainly discussed here.
To examine the effectiveness of percutaneous endoscopic gastrostomy or other enteral tube feeding in people with ALS, compared to oral feeds without enteral tube feeding on: 1. survival; 2. nutritional status; 3. quality of life. To examine the incidence of minor and major complications of percutaneous endoscopic gastrostomy (PEG) and other enteral tube feeding procedures in people with ALS.
On 3 January 2020 and 6 February 2021, we searched the Cochrane Neuromuscular Specialised Register, CENTRAL, MEDLINE. Embase, ClinicalTrials.gov and WHO ICTRP. We screened the results to identify randomized controlled studies on enteral tube feeding in ALS. We reviewed all references from the search in published articles to identify any additional references.
We included randomized controlled trials (RCTs), quasi-RCTs, and cross-over trials evaluating the effectiveness and complications of PEG or other enteral tube feeding placement in ALS.
We used standard methodological procedures expected by Cochrane.
We found no RCTs or quasi-RCTs comparing the effectiveness of enteral tube feeding versus oral feeds without enteral tube feeding.
AUTHORS' CONCLUSIONS: There are no RCTs or quasi-RCTs to indicate whether enteral tube feeding is effective compared to continuation of oral feeding for any of the outcome measures. Such RCTs are very unlikely to be performed for ethical reasons. RCTs evaluating the effect of different enteral tube insertion techniques and timings of tube placement on survival and quality of life of people with ALS dysphagia are feasible and warranted.
对于肌萎缩侧索硬化症(ALS)患者(又称运动神经元病(MND)),维持充足的营养至关重要。对有吞咽困难(吞咽障碍)的患者提供肠内管饲,以防止体重下降和吸入性肺炎。在各种肠内管饲中,经皮内镜下胃造口术(PEG)是为 ALS 患者提供的典型手术,这里主要讨论这种手术。
比较经皮内镜下胃造口术或其他肠内管饲与不进行肠内管饲的口服喂养在以下方面的效果:1. 生存率;2. 营养状况;3. 生活质量。观察经皮内镜下胃造口术(PEG)和其他肠内管饲在 ALS 患者中的轻微和严重并发症的发生率。
我们于 2020 年 1 月 3 日和 2021 年 2 月 6 日检索了 Cochrane 神经肌肉疾病组专业注册库、CENTRAL、MEDLINE、Embase、ClinicalTrials.gov 和世卫组织国际临床试验注册平台。我们筛选结果以确定关于 ALS 肠内管饲的随机对照研究。我们查阅了从发表文章中检索到的参考文献,以确定任何其他参考文献。
我们纳入了评价 PEG 或其他肠内管饲在 ALS 中的有效性和并发症的随机对照试验(RCT)、准 RCT 和交叉试验。
我们使用 Cochrane 预期的标准方法学程序。
我们未发现比较肠内管饲与不进行肠内管饲的口服喂养的有效性的 RCT 或准 RCT。
由于伦理原因,不太可能开展 RCT 或准 RCT 来确定与继续口服喂养相比,肠内管饲在任何结局指标上是否有效。对于有吞咽障碍的 ALS 患者,评估不同肠内管插入技术和管饲时间对生存率和生活质量的影响的 RCT 是可行和有必要的。